Becker's Hospital Review

FDA proposes new framework for clinical drug trial designs

FDA proposes framework clinical trial designs to guide Bayesian methods, improving efficiency in drug development for rare and pediatric conditions.
JSTOR Daily

Bayesian MAP estimation using Gaussian and diffused-gamma prior

The Canadian Journal of Statistics / La Revue Canadienne de Statistique, Vol. 46, No. 3 (September/septembre 2018), pp. 399-415 (17 pages) For sparse and high-dimensional data analysis, a valid ...
Pharmabiz

US FDA issues guidance on modernizing statistical methods for clinical trials

US FDA issues guidance on modernizing statistical methods for clinical trials: Maryland Wednesday, January 14, 2026, 09:00 Hrs [IST] The US Food and Drug Administration today publ ...
National Bureau of Economic Research

Bayesian Inference in IV Regressions

It is well known that standard frequentist inference breaks down in IV regressions with weak instruments. Bayesian inference with diffuse priors suffers from the same problem. We show that the issue ...
JSTOR Daily

Bayesian learning with multiple priors and nonvanishing ambiguity

The existing models of Bayesian learning with multiple priors by Marinacci (Stat Pap 43:145–151, 2002) and by Epstein and Schneider (Rev Econ Stud 74:1275–1303, 2007) formalize the intuitive notion ...